The method reduces the timeline required to carry out such assessments with classical methods from about a year to several weeks, and has the potential to greatly enhance surveillance efforts, transforming reactive monitoring into proactive forecasting.
Abstract
Influenza viruses evade vaccine and infection mediated immunity by accumulating mutations in their hemagglutinin (HA) protein. Predicting this evolution might be possible via selective mutational scanning (SMS) – the generation of many specific mutants of interest from currently circulating viruses and characterizing their escape potential and fitness with high accuracy (Mögling 2016). However, this task is challenging, even when focusing on a reduced set of key HA positions (Koel et al. 2013). Here we describe a high-throughput SMS method to address this challenge. Our approach consists of a three-stage pipeline: (1) a parallel optimized virus rescue process that generates balanced target mutant virus libraries (2) an assay to assess replicative fitness and neutralisation of these variants as a mixture, and (3) a bespoke statistical model to quantify statistically significant differences between these observables. We tested the pipeline on libraries of up to 134 variants finding excellent correlation to classical hemagglutination inhibition (HI) and plaque growth assays used to assess antigenic phenotype and replicative fitness respectively, as well as remarkable repeatability overall. Notably, the method reduces the timeline required to carry out such assessments with classical methods from about a year to several weeks. By enabling rapid and efficient characterization of influenza virus variants, this approach has the potential to greatly enhance surveillance efforts, transforming reactive monitoring into proactive forecasting.
A high-throughput aptamer engineering platform that combines a random-rational hybrid library diversification with repurposed MiSeq screening to rapidly reprogram aptamers against emerging SARS-CoV-2 spike variants is demonstrated, demonstrating a rapid and sequence-resolved aptamer engineering platform for adapting ap...
Yu-Jie He, Zhenglin Yang, Yu-An Kuo et al.· ACS Nano· 0 citations
Anticipating how mutations change viral fitness is central to genomic surveillance and vaccine design, yet the supervised phenotype data behind the most accurate variant-effect predictors are unavailable for most emerging pathogens. We ask how far label-free scoring can go using only sequences, their evolutionary histo...
S. Aris-Brosou, Matthieu Vilain· bioRxiv· 0 citations
Anticipating the effects of mutations in viral proteins is important for the development of therapeutics and control strategies but remains challenging as mutation phenotypes are shaped by complex overlapping sequence, structural and evolutionary constraints. Machine-learning approaches to mutation-effect prediction ha...
Sebastian Bowyer, David J. Allen, N. Furnham· bioRxiv· 0 citations
Summary Emerging infectious diseases and late-stage cancers demand rapid, sensitive, and deployable diagnostics. Here, we present HOMEBRED (highly sensitive & specific omnipresent multipurpose endonuclease based reliable detection), a CRISPR-based platform capable of detecting human and animal pathogens (viral/bacteria...
Adnan Asadbeigi, Hassan Fazilaty, M. Saffari et al.· iScience· 0 citations
The accurate characterization of human immunodeficiency virus (HIV) genetic diversity and drug resistance is critical for effective surveillance and treatment, yet current sequencing technologies face limitations in sensitivity and scalability for community-level implementation. We present G-HIV, an integrated platform...
P. Fu, Zi-Zhen Tang, Wen-Jie Chai et al.· Microorganisms· 0 citations